Related Experiment Video
Updated: Feb 25, 2026
07:49
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
2.0K
Kyoto Congestive Heart Failure (KCHF) study: rationale and design
Erika Yamamoto1, Takao Kato1, Neiko Ozasa1
1Department of Cardiovascular Medicine, Graduate School of Medicine Kyoto University, Kyoto, Japan.
ESC Heart Failure
|August 4, 2017
Summary
This study examines trends in acute decompensated heart failure (ADHF) patient characteristics and management in Japan. Findings will inform future heart failure clinical practice and policy decisions.
Area of Science:
- Cardiology
- Clinical Research
- Public Health
Background:
- Recent medical advancements have significantly altered heart failure patient management.
- Understanding current trends in acute decompensated heart failure (ADHF) is crucial for effective care.
- There is a need to evaluate contemporary ADHF patient profiles and treatment strategies in Japan.
Purpose of the Study:
- To assess recent trends in clinical characteristics of ADHF patients in Japan.
- To evaluate current management strategies for ADHF.
- To determine the short-term and long-term prognosis of ADHF patients.
Main Methods:
- Prospective, observational, multicenter cohort study (Kyoto Congestive Heart Failure study).
- Enrollment of consecutive ADHF patients from 19 Japanese hospitals (November 2014 - March 2016).
- Collection of anthropometric, socio-economic, and clinical data; 2-year longitudinal follow-up for a subgroup (n=1500).
Main Results:
- Data collection ongoing for 4000 enrolled ADHF patients.
- Detailed clinical and management data will be gathered from admission to discharge.
- Longitudinal follow-up data for 1500 patients will provide long-term outcome insights.
Conclusions:
- The Kyoto Congestive Heart Failure study will offer valuable real-world insights into ADHF patient care in Japan.
- Findings are expected to be essential for future clinical practice guidelines and health policy development.
- This research will contribute significantly to improving heart failure management strategies.
More Related Videos
Related Concept Videos
01:30Heart Failure V: Medical Management
400
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
400
01:29Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
476
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
476
01:22Heart Failure VI: Adjunct Therapies
442
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
442
01:22Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
649
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
649